Tag Archives: CHRS

Top 10 Stocks To Buy For 2019

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we’re talking about! Here is some more information if you’re curious.

Welcome to another edition of “3 Things In Biotech,” a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.

Mallinckrodt’s jaundice drug rejected by the FDA

Company: Mallinckrodt (NYSE:MNK)

Therapy: Stannsoporfin

Disease: Severe jaundice

News: MNK announced that a joint advisory committee at the FDA has voted against the risk-benefit profile of its medication stannsoporfin, which was intended to prevent severe hemolysis in newborns who are at risk of severe jaundice. The company guided that it would seek FDA input on what further data might be required in order to get a positive vote in the future.

Looking forward: And so the stannsoporfin story ends…for now! At this time, this looks like a very expensive ($80 million) mistake on the part of MNK, but I think it’s reasonable to expect that it’ll be able to resolve the data issues that sunk this application. But that’s going to take some serious time, and you can probably put this one in the back of your mind for at least another year, I’d wager.

Top 10 Stocks To Buy For 2019: Coherus BioSciences, Inc.(CHRS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Coherus Biosciences (NASDAQ: CHRS) and Allena Pharmaceuticals (NASDAQ:ALNA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation.

  • [By Maxx Chatsko]

    Shares of Coherus BioSciences (NASDAQ:CHRS) gained nearly 49% last month, according to data provided by S&P Global Market Intelligence. The company announced a global settlement with AbbVie that will allow the small-cap biopharma to commercialize a biosimilar to Humira, which was developed as CHS-1420. The pair had previously sparred over patents related to formulating the antibody.

  • [By Maxx Chatsko]

    Shares of Coherus BioSciences (NASDAQ:CHRS) fell over 18% last month, according to data provided by S&P Global Market Intelligence.

    The biopharma stock erupted higher in July after Coherus announced that the Committee for Medicinal Products for Human Use (CHMP) — a European Union regulatory body that makes recommendations to the European Medicines Agency (EMA), which is the equivalent to the U.S. Food and Drug Administration — would reconsider the company’s application for a generic version of Neulasta (pegfilgrastim). That put it on track to getting its first commercial product on the market.

  • [By Stephan Byrd]

    Krystal Biotech (NASDAQ:KRYS) and Coherus Biosciences (NASDAQ:CHRS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, profitability, institutional ownership and dividends.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Coherus Biosciences (CHRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Buy For 2019: Sohu.com Inc.(SOHU)

Advisors’ Opinion:

  • [By Daniel Sparks]

    Shares of Chinese internet company Sohu.com (NASDAQ:SOHU) fell as much as 11.8% on Wednesday, following the company’s first-quarter earnings release. The stock is down 8.4% at the time of this writing.

  • [By Rick Munarriz]

    The market isn’t warming up to Sohu.com’s (NASDAQ:SOHU) latest financial report. Its shares are hitting their lowest levels since the summer of 2007 after the Chinese online advertising, search, and gaming specialist posted disappointing first-quarter results on Wednesday morning. 

  • [By Rick Munarriz]

    Lumber Liquidators (NYSE:LL), Camping World Holdings (NYSE:CWH), and Sohu.com (NASDAQ:SOHU) have taken a beating this year. They’re among the biggest losers through the first three quarters of 2018. Let’s go over why I think they have a shot at bouncing back in the next three months.

  • [By Rick Munarriz]

    It’s now been seven months since Sohu.com (NASDAQ:SOHU) completed its objective of spinning off Sogou. Sogou had been the fastest growing component at Sohu for years. It should have taken off after trading on its own merits, but that failed to happen. Though the shares inched slightly higher in their first few days of trading, Sogou has spent most of its time since late November as a broken IPO until it finally cracked the $13 ceiling today in intraday trading.

  • [By Anders Bylund]

    Sogou’s shares are prone to big swings for a couple of simple reasons.

    As a Chinese business, many American investors don’t feel connected to Sogou’s business and might not have access to some important sources of information about this company and its stock. Though Sogou has been around for nearly a decade now, it only entered the public markets in November of 2017. It’s a new ticker, untested on the market, and not always easily understood through year-over-year or longer-term analyses. At the IPO, Chinese internet giants Tencent (NASDAQOTH:TCEHY) and Sohu.com (NASDAQ:SOHU) combined for a total ownership of 82% of Sogu’s business. Those stakes later declined to 71%, but Sohu and Tencent remain Sogou’s largest shareholders, with 96% of the voting power in shareholder elections and votes. Regular investors hold a very small stake in Sogou, which tends to boost the stock’s volatility.

    Moreover, Chinese regulators launched an investigation of Sogou in June, forcing the company to shut down parts of its online advertising operations for 10 days in early July. The company is accused of showing video ads that insulted a national hero. That blackout will reduce Sogou’s third-quarter revenues by a significant but unannounced amount.

  • [By Rick Munarriz]

    Sohu.com (NASDAQ:SOHU) is still struggling to fire on all cylinders, but investors nonetheless bid shares of the dot-com pioneer higher on Friday after it posted mixed fourth-quarter results. Revenue clocked in at $482.2 million for the final three months of 2018, a 5% decline from a year earlier, but a 5% sequential improvement. 

Top 10 Stocks To Buy For 2019: LGI Homes, Inc.(LGIH)

Advisors’ Opinion:

  • [By Tyler Crowe]

    This isn’t to say that investing in homebuilding is an awful idea — the trends mentioned above are incredibly strong indicators that investing in housing can pay off. What matters is you have to be incredibly discerning when selecting the business in which you want to invest. To me, there are only two stocks that are really worth exploring as potential investments: LGI Homes (NASDAQ:LGIH) and NVR Inc. (NYSE:NVR). Here’s why these two homebuilders stand out among the crowd.

  • [By ]

    LG Homes (LGIH) : “I like Lennar (LEN) and I also like Toll Brothers (TOL) .”

    GrubHub (GRUB) : “I’ve been riding this one for a long time. It might be time to take some profits. “

  • [By Neha Chamaria, Jason Hall, and Dan Caplinger]

    So, when we asked three of our Motley Fool contributors to each name a stock that has doubled and still has room to grow, they picked lululemon athletica (NASDAQ:LULU), LGI Homes Inc (NASDAQ:LGIH), and XPO Logistics (NYSE:XPO). Here’s why.

  • [By Shane Hupp]

    LGI Homes Inc (NASDAQ:LGIH) – Wedbush decreased their Q2 2019 earnings per share (EPS) estimates for shares of LGI Homes in a report released on Friday, July 6th. Wedbush analyst J. Mccanless now anticipates that the financial services provider will post earnings per share of $1.58 for the quarter, down from their previous forecast of $1.61. Wedbush has a “Neutral” rating and a $65.00 price objective on the stock. Wedbush also issued estimates for LGI Homes’ Q3 2019 earnings at $2.13 EPS and Q4 2019 earnings at $2.79 EPS.

Top 10 Stocks To Buy For 2019: T. Rowe Price Group, Inc.(TROW)

Advisors’ Opinion:

  • [By ]

    T Rowe Price (Nasdaq: TROW) — It has been a tough stretch for many money managers, as investors siphon assets away from traditional mutual funds and deposit them in passive exchange-traded funds (ETFs). But T. Rowe Price bucked the trend and attracted $2.7 billion in net inflows last quarter, raising its assets under management (AUM) to $1.08 trillion.

  • [By Chris Lange]

    The stock posting the largest daily percentage loss in the S&P 500 ahead of the close was T. Rowe Price Group, Inc. (NASDAQ: TROW) which fell about 5% to $107.70. The stock’s 52-week range is $81.77 to $127.43. Volume was about 2.5 million compared to the daily average volume of 1.1 million.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on T. Rowe Price Group (TROW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Press coverage about T. Rowe Price (NASDAQ:TROW) has trended somewhat positive on Wednesday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. T. Rowe Price earned a news impact score of 0.20 on Accern’s scale. Accern also assigned media stories about the asset manager an impact score of 47.382716620203 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By ]

    T Rowe Price (Nasdaq: TROW) — It has been a tough stretch for many money managers, as investors siphon assets away from traditional mutual funds and deposit them in passive exchange-traded funds (ETFs). But T. Rowe Price bucked the trend and attracted $2.7 billion in net inflows last quarter, raising its assets under management (AUM) to $1.08 trillion.

  • [By Max Byerly]

    T. Rowe Price Group Inc (NASDAQ:TROW) Director Robert F. Maclellan sold 5,000 shares of T. Rowe Price Group stock in a transaction on Wednesday, May 30th. The shares were sold at an average price of $122.58, for a total value of $612,900.00. Following the completion of the transaction, the director now owns 13,769 shares in the company, valued at $1,687,804.02. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Top 10 Stocks To Buy For 2019: JA Solar Holdings, Co., Ltd.(JASO)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Bank of America Corp. (NYSE: BAC) leads a strong day of earnings reports on Wall Street. The commercial banking giant was expected to report earnings per share (EPS) of $0.57 on top of $22.4 billion in revenue. The company topped both numbers, including EPS of $0.63. The company said its performance was bolstered by stronger profit margins, the 2017 GOP tax plan, and higher revenue from banking fees. President Donald Trump will meet with Russian President Vladimir Putin in Helsinki, Finland. Trump could request that Russia assist with the denuclearization of North Korea during their summit. Trump has said that he expects that he and Putin will have an “extraordinary friendship” at the conclusion of the event. The meeting comes just days after the U.S. government announced 12 indictments against Russian officials on charges of conspiracy to interfere with the 2016 presidential election. Global growth is back in focus after China announced second-quarter GDP expectations. The government announced that Q2 GDP came in at 6.7% as the country has been cracking down on risky credit offerings. Markets are continually worried about China’s Shanghai Composite – which recently entered bear territory. The third quarter will be interesting for markets as trade tensions accelerate between the United States and China.
    Four Stocks to Watch Today: NFLX, AMZN, TWTR, CAT
    Shares of Netflix Inc. (Nasdaq: NFLX) are in focus as the company prepares to report earnings after the bell. Wall Street analysts project that the company will report EPS of $0.80 on top of $3.93 billion in revenue. Analysts will be paying close attention to whether the online-streaming giant has been able to continue to aggressively increase its international user base. Amazon.com Inc. (Nasdaq: AMZN) is generating buzz as the company prepares to kick-start its annual Prime Day. The annual shopping event will take place starting this evening and stretch through Tuesday. According to the website Reta

  • [By Travis Hoium]

    The impact will have ripple effects across the industry. Major manufacturers like Canadian Solar (NASDAQ:CSIQ), JinkoSolar (NYSE:JKS), Hanwha Q Cells (NASDAQ:HQCL), and JA Solar (NASDAQ:JASO) will see margins squeezed as volume and sales prices fall. They were all enjoying higher margins and strong demand in early 2018, so the could reverse to net losses later this year. 

  • [By Rich Smith]

    Fearing that prospects for the solar industry are dimming, yesterday analysts at Roth Capital bailed on the solar industry wholesale, downgrading shares of Hanwha Q Cells, JA Solar Holdings (NASDAQ:JASO), and ReneSola to sell. This morning, Merrill Lynch showed signs it’s planning to join the rush to the exits as well, downgrading American solar manufacturer First Solar (NASDAQ:FSLR) to neutral.

  • [By Garrett Baldwin]

    We’re about to reveal a little wealth secret that could unlock the trade of a lifetime. Money Morning Special Situation Strategist Tim Melvin takes you inside what could easily be a 10-bagger for investors in the weeks ahead. Read more right here.

    The Top Stock Market Stories for Tuesday
    The Euro has plunged to its lowest point against the U.S. dollar in 2018 thanks to political problems in Europe. The breakdown of power in Italy has raised new concerns about the nation’s ability to repay its debts, as the spread between German and Italian bonds has widened. Market instability has also spread to Spain where the nation’s parliament is preparing to vote on whether to oust Prime Minister Mariano Rajoy and his party. Oil prices slid one news that OPEC and Russia will consider hikes in production during a meeting in Vienna, Austria on June 22nd. The news accompanied reports that U.S. production is expected to rise throughout the summer. The price of WTI oil sat at $67.20 per barrel. The Brent crude oil price recovered this morning, adding 1% to hit $76.12. Canadian banks are under pressure this morning over a major breach by cyber criminals. The Bank of Montreal (NYSE: BMO) and the Canadian Imperial Bank of Commerce (NYSE: CM) – the two largest banking institutions in the country – announced that roughly 90,000 customers’ data may have been stolen. This would be the first major cybersecurity event to happen in Canada involving financial firms.
    Three Stocks to Watch Today: CRM, SBUX, MOMO
    com (NYSE: CRM) will lead a busy day of earnings reports on Wall Street. The cloud computing giant is set to report fiscal first quarter 2019 numbers after the bell on Tuesday. The average analyst projection calls for a 46% jump in EPS of $0.46 on top of a 23% gain in revenue to $2.94 billion. Starbucks’ Corporation (Nasdaq: SBUX) will temporarily close about 8,000 locations on Tuesday to train roughly 175,000 employees on racial bias. The training sessions were

  • [By Ethan Ryder]

    JA Solar (NASDAQ:JASO) is scheduled to be posting its quarterly earnings results before the market opens on Monday, July 2nd. Analysts expect JA Solar to post earnings of $0.20 per share for the quarter.

Top 10 Stocks To Buy For 2019: Tarena International, Inc.(TEDU)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of Tarena International Inc. (ADR) (NASDAQ:TEDU) plummeted 22.1% on Tuesday after the China-based professional education services provider announced disappointing first-quarter 2018 results. 

  • [By Joseph Griffin]

    Schroder Investment Management Group trimmed its holdings in Tarena International Inc (NASDAQ:TEDU) by 7.9% in the second quarter, Holdings Channel reports. The fund owned 1,716,054 shares of the business services provider’s stock after selling 146,939 shares during the period. Schroder Investment Management Group’s holdings in Tarena International were worth $12,922,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Credit Suisse Group cut shares of Tarena International (NASDAQ:TEDU) from an outperform rating to a neutral rating in a report published on Thursday morning, Marketbeat reports.

Top 10 Stocks To Buy For 2019: Peapack-Gladstone Financial Corporation(PGC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Thrivent Financial for Lutherans lifted its position in shares of Peapack-Gladstone Financial Co. Common Stock (NASDAQ:PGC) by 16.3% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 48,531 shares of the financial services provider’s stock after purchasing an additional 6,789 shares during the quarter. Thrivent Financial for Lutherans owned about 0.26% of Peapack-Gladstone Financial Co. Common Stock worth $1,621,000 as of its most recent filing with the SEC.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Peapack-Gladstone Financial Co. Common Stock (PGC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Bank of N.T. Butterfield & Son (NYSE: NTB) and Peapack-Gladstone Financial Co. Common Stock (NASDAQ:PGC) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends.

Top 10 Stocks To Buy For 2019: Evoke Pharma, Inc.(EVOK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Evoke Pharma (EVOK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Here are some of the news stories that may have impacted Accern’s rankings:

    Get Evoke Pharma alerts:

    Evoke Pharma (EVOK) Given a $9.00 Price Target by HC Wainwright Analysts (americanbankingnews.com) Evoke Pharma (EVOK) Announces FDA Acceptance of Gimoti NDA (zacks.com) FDA to Review Gimoti for Diabetic Gastroparesis in Adult Women (empr.com) Evoke Pharma’s Gimoti™ NDA Accepted for FDA Review (finance.yahoo.com)

    Shares of NASDAQ EVOK traded up $0.08 during mid-day trading on Friday, reaching $2.44. 56,399 shares of the company’s stock were exchanged, compared to its average volume of 83,661. The stock has a market cap of $42.58 million, a PE ratio of -2.94 and a beta of 1.46. Evoke Pharma has a 52-week low of $1.85 and a 52-week high of $4.09.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Evoke Pharma (EVOK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Buy For 2019: CommVault Systems, Inc.(CVLT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CommVault Systems (CVLT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CommVault Systems (CVLT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    CommVault Systems, Inc. (NASDAQ:CVLT) has been assigned an average rating of “Buy” from the eleven analysts that are presently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $76.57.

Top 10 Stocks To Buy For 2019: BlackRock Multi-Sector Income Trust(BIT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Northwestern Mutual Wealth Management Co. increased its stake in Blackrock Multi-Sector Income Trust (NYSE:BIT) by 23.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 82,769 shares of the investment management company’s stock after purchasing an additional 15,675 shares during the quarter. Northwestern Mutual Wealth Management Co. owned 0.22% of Blackrock Multi-Sector Income Trust worth $1,415,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    First Bitcoin (CURRENCY:BIT) traded up 12.4% against the US dollar during the one day period ending at 7:00 AM E.T. on July 1st. One First Bitcoin coin can now be bought for approximately $0.0113 or 0.00000177 BTC on major exchanges. Over the last week, First Bitcoin has traded 4% lower against the US dollar. First Bitcoin has a market capitalization of $0.00 and approximately $13.00 worth of First Bitcoin was traded on exchanges in the last day.

  • [By Max Byerly]

    BitRewards (CURRENCY:BIT) traded 7.8% lower against the US dollar during the 24-hour period ending at 19:00 PM E.T. on August 13th. One BitRewards token can now be purchased for approximately $0.0017 or 0.00000027 BTC on exchanges including IDEX and HitBTC. BitRewards has a total market capitalization of $414,691.00 and $106,200.00 worth of BitRewards was traded on exchanges in the last 24 hours. Over the last week, BitRewards has traded down 31.6% against the US dollar.

Top Performing Stocks To Invest In Right Now

Investors had a few big concerns about Winnebago’s (NYSE:WGO) business trends heading into this past week’s report. For one thing, the recreational vehicle market is slowing in 2018 after expanding at a double-digit pace in each of the last eight years. And three months ago the manufacturer revealed profitability struggles in its motorized RV segment that could worsen due to rising prices on steel and aluminum.

The company put those concerns to rest in its fiscal third-quarter report last Wednesday, at least for the short term. 

Image source: Getty Images.

Growth is holding up just fine

Winnebago posted slowing backlog growth in late March, and that led Wall Street to project just a 14% sales uptick for the quarter. Winnebago outpaced that result, landing on an 18% revenue gain, up to $562 million. 

The growth was mainly due to a 33% spike in its towables division as both the Winnebago brand and the newly acquired Grand Designs brand gained market share. The motorized RV segment sped up slightly, too, rising to a 3% increase from 2% in the prior quarter. Most importantly, executives noticed healthy demand for Winnebago’s latest product lineup. “Our new product launches are performing well,” CEO Michael Happe said in a press release. 

Top Performing Stocks To Invest In Right Now: Summit Midstream Partners, LP(SMLP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Three high-yield dividend stocks that seem to be in danger of a dividend reduction are Summit Midstream Partners (NYSE:SMLP), Enbridge Energy Partners (NYSE:EEP), and Sunoco LP (NYSE:SUN). Investors are better off steering clear of this trio and considering safer options instead.

  • [By Max Byerly]

    Summit Midstream Partners (NYSE:SMLP) released its quarterly earnings data on Thursday. The pipeline company reported ($0.18) EPS for the quarter, missing the consensus estimate of $0.12 by ($0.30), MarketWatch Earnings reports. Summit Midstream Partners had a return on equity of 12.62% and a net margin of 17.59%. The business had revenue of $117.32 million during the quarter, compared to the consensus estimate of $106.68 million.

  • [By Matthew DiLallo]

    One of the many companies working to solve the Permian’s pipeline problems is Summit Midstream Partners (NYSE:SMLP). The master limited partnership (MLP) is currently working on a long-haul pipeline that would transport natural gas from the northwest portion of the region to a major hub in Texas. The project would not only provide needle-moving growth for Summit — and help support its sky-high 14.5%-yielding distribution — but it could be a crucial supply link for the industry.

  • [By Joseph Griffin]

    Summit Midstream Partners (NYSE:SMLP) insider Brad N. Graves sold 5,000 shares of the stock in a transaction dated Thursday, May 17th. The stock was sold at an average price of $15.53, for a total transaction of $77,650.00. Following the sale, the insider now owns 61,225 shares of the company’s stock, valued at approximately $950,824.25. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Summit Midstream Partners (SMLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Here are some of the media stories that may have effected Accern Sentiment’s rankings:

    Get Summit Midstream Partners alerts:

    Brad N. Graves Sells 5,000 Shares of Summit Midstream Partners (SMLP) Stock (americanbankingnews.com) US Capital Advisors Analysts Lift Earnings Estimates for Summit Midstream Partners (SMLP) (americanbankingnews.com) Summit Midstream Partners LP (SMLP): Shares Climb 4.56% (parkcitycaller.com) Summit Midstream Partners to Post FY2019 Earnings of $1.64 Per Share, US Capital Advisors Forecasts (SMLP) (americanbankingnews.com)

    NYSE:SMLP opened at $15.75 on Friday. Summit Midstream Partners has a one year low of $13.10 and a one year high of $24.75. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 1.05. The company has a market capitalization of $1.18 billion, a P/E ratio of 9.60 and a beta of 1.76.

Top Performing Stocks To Invest In Right Now: Polaris Industries Inc.(PII)

Advisors’ Opinion:

  • [By Rich Duprey]

    Polaris Industries (NYSE:PII) is the premier powersports vehicle manufacturer with its off-road vehicles, motorcycles, snowmobiles, utility vehicles, and boats. It’s even in the aftermarket parts and accessories market for Jeeps and trucks.

  • [By Stephan Byrd]

    SevenBridge Financial Group LLC lowered its stake in shares of Polaris Industries Inc. (NYSE:PII) by 31.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,432 shares of the company’s stock after selling 1,129 shares during the quarter. SevenBridge Financial Group LLC’s holdings in Polaris Industries were worth $279,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Polaris Industries (PII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to

Top Performing Stocks To Invest In Right Now: UTStarcom Holdings Corp(UTSI)

Advisors’ Opinion:

  • [By Logan Wallace]

    TheStreet cut shares of UTStarcom (NASDAQ:UTSI) from a c rating to a d+ rating in a report issued on Monday morning.

    UTStarcom opened at $4.93 on Monday, MarketBeat reports. UTStarcom has a 52-week low of $4.95 and a 52-week high of $4.99.

  • [By Joseph Griffin]

    ADVA Optical Networking (OTCMKTS: ADVOF) and UTStarcom (NASDAQ:UTSI) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and valuation.

  • [By Max Byerly]

    ADVA Optical Networking (OTCMKTS: ADVOF) and UTStarcom (NASDAQ:UTSI) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Top Performing Stocks To Invest In Right Now: Black Box Corporation(BBOX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Juniper Networks (NYSE: JNPR) and Black Box (NASDAQ:BBOX) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends.

  • [By Joseph Griffin]

    Media stories about Black Box (NASDAQ:BBOX) have been trending somewhat positive on Monday, Accern reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Black Box earned a coverage optimism score of 0.09 on Accern’s scale. Accern also assigned news headlines about the technology company an impact score of 48.0509907143742 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Paul Ausick]

    Black Box Corp. (NASDAQ: BBOX) traded flat Thursday to match its 52-week low of $0.75 after closing Tuesday at $0.75. The stock’s 52-week high is $8.45. Volume was more than 40 times the daily average of about 180,000 shares. The company warned on Tuesday that it could face bankruptcy. Shares rose in Thursday trading and are on track to post a gain of about 30% for the day.

  • [By Logan Wallace]

    Liberum Capital reiterated their hold rating on shares of Tritax Big Box REIT (LON:BBOX) in a report published on Friday morning.

    A number of other equities research analysts also recently issued reports on the stock. Numis Securities boosted their price target on shares of Tritax Big Box REIT from GBX 150 ($1.96) to GBX 153 ($2.00) and gave the company a hold rating in a research note on Monday, August 20th. Barclays started coverage on shares of Tritax Big Box REIT in a research note on Tuesday, October 2nd. They issued an equal weight rating and a GBX 160 ($2.09) price target on the stock.

  • [By Max Byerly]

    Liberum Capital reissued their hold rating on shares of Tritax Big Box REIT (LON:BBOX) in a research note issued to investors on Friday.

    Separately, Numis Securities lifted their target price on Tritax Big Box REIT from GBX 150 ($1.95) to GBX 153 ($1.99) and gave the company a hold rating in a research report on Monday, August 20th.

Top Performing Stocks To Invest In Right Now: Coherus BioSciences, Inc.(CHRS)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Coherus BioSciences (NASDAQ:CHRS) gained nearly 49% last month, according to data provided by S&P Global Market Intelligence. The company announced a global settlement with AbbVie that will allow the small-cap biopharma to commercialize a biosimilar to Humira, which was developed as CHS-1420. The pair had previously sparred over patents related to formulating the antibody.

  • [By Joseph Griffin]

    Coherus Biosciences Inc (NASDAQ:CHRS) insider Barbara K. Finck sold 1,760 shares of the firm’s stock in a transaction that occurred on Monday, September 10th. The shares were sold at an average price of $18.58, for a total value of $32,700.80. Following the completion of the sale, the insider now owns 38,803 shares in the company, valued at $720,959.74. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Coherus Biosciences (CHRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca
  • [By Logan Wallace]

    Coherus Biosciences (NASDAQ: CHRS) and Allena Pharmaceuticals (NASDAQ:ALNA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Coherus Biosciences (CHRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Safest Stocks To Buy Right Now

If you are an adult buying a gift for your father next weekend, he may be old, and perhaps very old. Many people in their 50s and 60s still have fathers. Stocks for Dad? Probably conservative ones, and not too expensive.

Verizon (NYSE: VZ) is one of the safest investments among U.S. stocks. It has not done much to make people money on price alone over the last year. Verizon trades at $49, near the middle of 52-week high/low range of $55 and $43. However, the stock boasts a yield of of 4.8%. The company’s rock solid balance sheet and cash flow virtually guarantee that dividend, even in an economic downturn. Verizon’s revenue has been relatively flat around $120 billion for the last three years. Last year’s net was $21 billion, about flat from the previous year. Verizon’s biggest risk is margin erosion in the war for wireless subscribers in the U.S.

Hot Safest Stocks To Buy Right Now: MCBC Holdings, Inc.(MCFT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Shares of MCBC Holdings Inc (NASDAQ:MCFT) have received an average rating of “Buy” from the eight brokerages that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $28.08.

  • [By Ethan Ryder]

    MCBC Holdings (NASDAQ:MCFT) shares reached a new 52-week high and low during trading on Wednesday . The company traded as low as $30.42 and last traded at $30.27, with a volume of 14269 shares changing hands. The stock had previously closed at $29.28.

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69

Hot Safest Stocks To Buy Right Now: Ormat Technologies, Inc.(ORA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Nevro Corp. (NASDAQ: NVRO) fell 11.6 percent to $81.58 in pre-market trading after reporting wider-than-expected Q1 loss.
    Hertz Global Holdings, Inc. (NYSE: HTZ) shares fell 8.3 percent to $20.33 in pre-market trading after the company reported a wider-than-expected loss for its first quarter.
    Zillow Group, Inc. (NASDAQ: Z) fell 7.5 percent to $51.74 in pre-market trading. Zillow reported upbeat earnings for its first quarter, but issued weak sales guidance for the second quarter.
    Sanchez Energy Corporation (NYSE: SN) fell 7.2 percent to $3.11 in pre-market trading after reporting wider-than-expected Q1 loss.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 5.5 percent to $4.14 in pre-market trading after rising 11.17 percent on Monday.
    Albemarle Corporation (NYSE: ALB) fell 5.1 percent to $95.00 in pre-market trading. Albemarle declared a quarterly dividend of $0.335 per share.
    Tata Motors Limited (NYSE: TTM) fell 4.8 percent to $23.80 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) fell 4.5 percent to $57.14 in pre-market trading after reporting Q1 results.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares fell 4.3 percent to $2.25 in pre-market trading after gaining 1.73 percent on Monday.
    51job, Inc. (NASDAQ: JOBS) shares fell 4.2 percent to $93 in pre-market trading after rising 3.55 percent on Monday

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
    Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
    Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
    RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
    Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
    Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
    Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
    CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering

  • [By Ethan Ryder]

    Orange (EPA:ORA) received a €16.50 ($19.19) price target from Credit Suisse Group in a research note issued to investors on Wednesday. The firm currently has a “buy” rating on the stock. Credit Suisse Group’s price target indicates a potential upside of 17.61% from the stock’s previous close.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Ormat Technologies (ORA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Safest Stocks To Buy Right Now: Coherus BioSciences, Inc.(CHRS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca

Best Warren Buffett Stocks To Buy Right Now

Since 2014 Hershey (NYSE:HSY) has been struggling a lot with its foreign operations. This has been due to the facts that the general business environment has been rather weak in foreign countries where Hershey is operating, that a strong dollar has hurt the sales and especially that the Chinese market has proved to be much more difficult than expected.

One other thing that I am even more worried about is the way the current management at Hershey is using adjusted earnings in its earnings releases. I do not know about the rest of the investors, but at least for me, when management is constantly talking about adjusted earnings instead of actual earnings, it is a warning sign. I can fully understand one-time business costs, such as transactions costs related to a major acquisition. In that type of a situation it is perfectly fine to use adjusted earnings because they give more visibility about the true earnings power of a company. However, when a company starts to constantly categorize regular annual costs as one-time costs, like Hershey is doing with business realignment costs, you should be very worried. In the case of Hershey, I would consider the business realignment costs as regular costs as they have been there for several years. This is a bit like when Warren Buffett is recommending that investors walk away if management is constantly referring to EBIT figures.

Best Warren Buffett Stocks To Buy Right Now: Conn's, Inc.(CONN)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Best Buy Co outperforming potential peersactive in electronics retailing such asmid capAaron’s, Inc (NYSE: AAN)and small cap CONN’S, Inc (NASDAQ: CONN):

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

  • [By Lisa Levin]

    Wednesday afternoon, the cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Conn's Inc (NASDAQ: CONN) and Wyndham Worldwide Corporation (NYSE: WYN).

Best Warren Buffett Stocks To Buy Right Now: Catalyst Biosciences, Inc. (CBIO)

Advisors’ Opinion:

  • [By Ashley Moore]

    Here is a list of the top 10 best small-cap stocks based on price gains per share so far in 2017:

    Company (Ticker)Price per Share% Change AquaBounty Technologies Inc. (Nasdaq: AQB)$14.338,646.99%Rennova Health Inc. (Nasdaq: RNVA)$3.133,333.73%China Gengsheng Minerals Inc. (OTCMKTS: CHGS)$0.021,718.18%Sunshine Heart Inc. (Nasdaq: SSH)$3.851,071.43%CTI BioPharma Corp. (Nasdaq: CTIC)$4.30991.76%Catalyst Biosciences Inc. (Nasdaq: CBIO)$6.22853.85%TearLab Corp. (Nasdaq: TEAR)$4.20707.85%Pulmatrix Inc. (Nasdaq: PULM)$3.86566.10%Real Goods Solar Inc. (Nasdaq: RGSE)$1.43498.75%Calithera Biosciences Inc. (Nasdaq: CALA)$11.70281.54%

  • [By Lisa Levin]

    Shares of Catalyst Biosciences Inc (NASDAQ: CBIO) were down around 27 percent to $5.36. Catalyst Biosciences reported the pricing of $18 million offering of Class A units at $5 per unit

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

Best Warren Buffett Stocks To Buy Right Now: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenMeritage Homes Corp(NYSE:MTH) last reported earnings to wrap up fiscal 2016, it left investors with reason to be concerned. The company finished the year with strong 15% home-closing revenue growth in the fourth quarter, 19% home-closing revenue growth for the full year, and a 15% jump in earnings per share for the year. Unfortunately, the homebuilder reported that its unit sales, and that its backlog of homes on order, were down from the year-ago period in the fourth quarter — not a positive metric considering the general strength of the new homes market and the company’s success in expanding and growing in recent years.

Best Warren Buffett Stocks To Buy Right Now: Southern Company (The)(SO)

Advisors’ Opinion:

  • [By Dustin Parrett]

    Natural gas just claimed another victory over clean coal, as Southern Co. (NYSE: SO) announced on June 28 it’s converting its failed $7.1 billion clean coal power plant into a natural gas-fired facility.

  • [By Paul Ausick]

    The Southern Co. (NYSE: SO) traded down about 1.9% Thursday and posted a new 52-week low of $45.08 after closing Wednesday at $45.96. The 52-week high is $53.51. Volume was about 5.4 million, about 15% above the daily average of around 4.8 million shares. The company had no specific news Thursday.

  • [By Paul Ausick]

    The Southern Co. (NYSE: SO) traded down about 2.9% Wednesday and posted a new 52-week low of $45.81 after closing Tuesday at $47.20. The 52-week high is $53.51. Volume was about 5.5 million, about 15% above the daily average of around 4.8 million shares. The company had no specific news Wednesday.

  • [By ]

    Under a single-payer system, healthcare becomes a regulated utility much like electricity with just a few large, best-in-class players. Athenahealth (Nasdaq: ATHN) could combine with Walgreen Boots Alliance (NYSE: WBA). Maybe each monolith will cover a specific region like Southern Company (NYSE: SO) and Consolidated Edison (NYSE: ED).

  • [By Paul Ausick]

    The Southern Co. (NYSE: SO) traded down about 1.7% Friday and posted a new 52-week low of $44.46 after closing Thursday at $45.25. The 52-week high is $53.51. Volume was over 6 million, about 20% above the daily average of around 4.8 million shares. The company was dropped from Neutral to Sell at Goldman Sachs on Thursday.

Best Warren Buffett Stocks To Buy Right Now: Westinghouse Air Brake Technologies Corporation(WAB)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Westinghouse Air Brake Technologies Corporation (WAB) scores highly based on my Warren Buffett-based model, which is based on the book Buffettology, and also the Peter Lynch-inspired approach that uses the method outlined by Lynch in One Up on Wall Street.

Best Warren Buffett Stocks To Buy Right Now: Coherus BioSciences, Inc.(CHRS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) shares rose 18.4 percent to $68.65 in pre-market trading as the company reported upbeat results for its first quarter.
    Jack in the Box Inc. (NASDAQ: JACK) shares rose 9.5 percent to $111.60 in the pre-market trading session after the company posted better-than-expected earnings for its second quarter. The company also disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba.
    Coherus Biosciences Inc (NASDAQ: CHRS) rose 9.8 percent to $24.20 in pre-market trading. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision.
    Qiwi PLC (NASDAQ: QIWI) rose 8.1 percent to $21.49 in pre-market trading after reporting strong quarterly results.
    Korea Electric Power Corporation (ADR) (NYSE: KEP) shares rose 7.9 percent to $20.00 in pre-market trading after dropping 4.33 percent on Tuesday
    Target Corporation (NYSE: TGT) shares rose 7.5 percent to $58.60 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
    AngloGold Ashanti Limited (ADR) (NYSE: AU) rose 4.3 percent to $11.71 in pre-market trading after falling 0.09 percent on Tuesday.
    Colgate-Palmolive Company (NYSE: CL) rose 4.1 percent to $74.53 in pre-market trading after the NY Post reported that the company might be up for sale for $100 per share.
    Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 4 percent to $2.35 in pre-market trading after declining 1.74 percent on Tuesday.
    Core Laboratories N.V. (NYSE: CLB) rose 3.6 percent to $109.00 in pre-market trading after gaining 0.39 percent on Tuesday.
    Clovis Oncology Inc (NASDAQ: CLVS) rose 3.2 percent to $51.15 in pre-market trading. JP Morgan upgraded Clovis Oncology from Neutral to Overweight.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Ben Levisohn]

    Today,Coherus BioSciences (CHRS) lost a patent case with AbbVie (ABBV) that would have allowed for a generic version of Humira. Citigroup’s Andrew Baum and Peter Verdult have the details:

    Agence France-Presse/Getty Images

    The Patent Trial and Appeal Boardjust announced that CHRSs IPR on the 166 Humira formulation patent was not instituted. We remind investors that Amgens IPR on the same 157 and 158 formulation patents were also not instituted. Any at risk launch on a formulation that potentially infringes 166, 157 or 158 would seem unlikely and carries a high risk thatAbbVie would attain a preliminary injunction. It is not clear whether either company could attempt launch with a formulation that does not infringe the patent estate. We note that Sandoz has uniquely not filed any IPR on any biosimilars. Sandoz has not announced the FDA has accepted their filing for their biosimilar adalimumab…We anticipate that the perceived historic relationship of the immunogenicity of Humira as it relates to dose stretching will form a key debate in the ongoing PTAB case…

    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

    Shares of AbbVie have climbed 5.6% to $59.18 at 3:05 p.m. today, while Coherus BioSciences has tumbled 11% to $25.18,Bristol-Myers Squibb has gained 3% to $52.56, andEli Lilly has risen 1.7% to $73.70.

  • [By Lisa Levin]

    Coherus Biosciences Inc (NASDAQ: CHRS) shares shot up 23 percent to $13.70 after the company announced plans to raise up to $150 million in a private placement.

great stocks to own

Several factors have been responsible for pushing the total market cap of cryptocurrencies higher. Shutterstock

The total market capitalization (market cap) of cryptocurrencies continues to grow, recently surpassing $170 billion and hitting a fresh, record high.

The total market cap of these digital assets rose to as much as $172.2 billion earlier today, according to CoinMarketCap. 

This figure represents a more than 850% increase from their value of $17.7 billion at the start of this year. 

Why does this innovative asset class continue to grow?

The crypto market is growing for several reasons, according to analysts.

A steady supply of Initial Coin Offerings (ICOs), a rising number of funds that trade cryptocurrencies and the sustained interest of investors are all contributing to this trend.

great stocks to own: Alexco Resource Corp(AXU)

Advisors’ Opinion:

  • [By Cameron Saucier]

    Alexco Resource (NYSEMKT: AXU) operates in two segments: an environmental services business and a mining company. Its mining segment explores developments in Canada, while its environmental segment provides consulting and project management services in the United States and Canada. AXU is up over 400% YTD. The stock has been steadily rising since January. It isn’t clear what’s driving AXU upwards, other than general investor speculation. The stock is trading at $1.72 per share as of Monday intraday.

great stocks to own: Actinium Pharmaceuticals, Inc.(ATNM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Actinium Pharmaceuticals Inc (NYSE: ATNM) were down 24 percent to $1.29. Actinium priced 8 million shares at $1.25 per share.

    Shineco Inc (NASDAQ: TYHT) was down, falling around 32 percent to $19.50. On Wednesday, Shineco priced IPO at $4.50 per share.

great stocks to own: HP Inc.(HPQ)

Advisors’ Opinion:

  • [By Matt Hogan]

    Apple EBITDA Margins vs Peers Chart Apple's EBITDA margins vs technology peers: Western Digital Corp. (NASDAQ: WDC), HP Inc. (NYSE: HPQ), Hewlett Packard Enterprise Co. (NYSE: HPE) and NetApp Inc. (NASDAQ: NTAP).

  • [By Anders Bylund]

    Shares of HP Inc. (NYSE:HPQ) rose 15.4% in February 2017, according to data from S&P Global Market Intelligence.

    So what

    The big jump came late in the month. HP reported first-quarter 2017 results on Feb. 22, leaving Wall Street’s estimates far behind despite modest revenue growth and flat earnings. Investors chose to ignore a gloomy slate of second-quarter guidance targets, and share prices soared as much as 10% higher the next day.

  • [By Chris Lange]

    HP Inc. (NYSE: HPQ) reported fiscal second-quarter financial results after markets closed Wednesday. The company said that it had $0.40 in earnings per share (EPS) and $12.39 billion in revenue, versus consensus estimates from Thomson Reuters that called for $0.39 in EPS and $11.88 billion in revenue. The same period from last year had $0.41 in EPS and $11.59 billion in revenue.

  • [By Peter Graham]

    The Q4 2016 earnings report for small cap 3D printer stock ExOne Co (NASDAQ: XONE) is scheduled for after the marketcloses onThursday (March 16th). 3D printer stocks had their day in the sun a fewyears ago, buthave been disappointing investors eversincethe 3Dbubble burst whileHP Inc (NYSE: HPQ) entering the printer market with its Jet Fusion 3D adds further headwinds. However,3D printershares appear to have stabilized as the short interest has largely been cleared out.

  • [By Alex Cho]

    That being the case, it wouldnt take substantial market share gains for AMD to reverse the multi-year decline in its processor business, as performance/watt is what will drive adoption from key PC makers like Dell, HP Inc (NYSE:HPQ)and Lenovo. AMD hasnt been very competitive in the MPU (microprocessor unit) segment for quite a while, but given the recent node shift to 14nm FinFET over at GlobalFoundries, and mention of new architecture by AMD earlier this year at COMPUTEX Taiwan, I get the impression that performance of Summit Ridge, i.e. Zen will match Skylake and will perhaps come in slightly slower than Kaby Lake.

great stocks to own: Coherus BioSciences, Inc.(CHRS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) shares rose 18.4 percent to $68.65 in pre-market trading as the company reported upbeat results for its first quarter.
    Jack in the Box Inc. (NASDAQ: JACK) shares rose 9.5 percent to $111.60 in the pre-market trading session after the company posted better-than-expected earnings for its second quarter. The company also disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba.
    Coherus Biosciences Inc (NASDAQ: CHRS) rose 9.8 percent to $24.20 in pre-market trading. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision.
    Qiwi PLC (NASDAQ: QIWI) rose 8.1 percent to $21.49 in pre-market trading after reporting strong quarterly results.
    Korea Electric Power Corporation (ADR) (NYSE: KEP) shares rose 7.9 percent to $20.00 in pre-market trading after dropping 4.33 percent on Tuesday
    Target Corporation (NYSE: TGT) shares rose 7.5 percent to $58.60 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
    AngloGold Ashanti Limited (ADR) (NYSE: AU) rose 4.3 percent to $11.71 in pre-market trading after falling 0.09 percent on Tuesday.
    Colgate-Palmolive Company (NYSE: CL) rose 4.1 percent to $74.53 in pre-market trading after the NY Post reported that the company might be up for sale for $100 per share.
    Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 4 percent to $2.35 in pre-market trading after declining 1.74 percent on Tuesday.
    Core Laboratories N.V. (NYSE: CLB) rose 3.6 percent to $109.00 in pre-market trading after gaining 0.39 percent on Tuesday.
    Clovis Oncology Inc (NASDAQ: CLVS) rose 3.2 percent to $51.15 in pre-market trading. JP Morgan upgraded Clovis Oncology from Neutral to Overweight.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Ben Levisohn]

    Today,Coherus BioSciences (CHRS) lost a patent case with AbbVie (ABBV) that would have allowed for a generic version of Humira. Citigroup’s Andrew Baum and Peter Verdult have the details:

    Agence France-Presse/Getty Images

    The Patent Trial and Appeal Boardjust announced that CHRSs IPR on the 166 Humira formulation patent was not instituted. We remind investors that Amgens IPR on the same 157 and 158 formulation patents were also not instituted. Any at risk launch on a formulation that potentially infringes 166, 157 or 158 would seem unlikely and carries a high risk thatAbbVie would attain a preliminary injunction. It is not clear whether either company could attempt launch with a formulation that does not infringe the patent estate. We note that Sandoz has uniquely not filed any IPR on any biosimilars. Sandoz has not announced the FDA has accepted their filing for their biosimilar adalimumab…We anticipate that the perceived historic relationship of the immunogenicity of Humira as it relates to dose stretching will form a key debate in the ongoing PTAB case…

    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

    Shares of AbbVie have climbed 5.6% to $59.18 at 3:05 p.m. today, while Coherus BioSciences has tumbled 11% to $25.18,Bristol-Myers Squibb has gained 3% to $52.56, andEli Lilly has risen 1.7% to $73.70.

  • [By Lisa Levin]

    Coherus Biosciences Inc (NASDAQ: CHRS) shares shot up 23 percent to $13.70 after the company announced plans to raise up to $150 million in a private placement.

great stocks to own: Trevena, Inc.(TRVN)

Advisors’ Opinion:

  • [By Chris Lange]

    Trevena Inc. (NASDAQ: TRVN) reported positive results from two late-stage clinical trials that work to treat post-surgical pain. The company intends to submit these results to the FDA for a marketing approval agreement in the fourth quarter. Previously, oliceridine was approved for a breakthrough designation by the agency.

  • [By Lisa Levin]

    Trevena Inc (NASDAQ: TRVN) shares dropped 36 percent to $4.55 despite a positive development in Phase 3 trials. Trevena announced positive top-line results from ongoing Phase 3 trials called "APOLLO-1" and "APOLLO-2." The studies evaluated the safety of Trevena's oliceridine therapy in patients for 48 hours following bunionectomy and 24 hours following abdominoplasty.

  • [By Paul Ausick]

    Trevena Inc. (NASDAQ: TRVN) dropped about 6.3% Thursday, to post a new 52-week low of $3.70 after closing at $3.95 on Wednesday. The stock’s 52-week high is $9.73. Volume was nearly 5 times the daily average of around 700,000 shares. The company’s pain-killing drug got mixed results in a trial result reported Tuesday.